Alterome is a clinical-stage biotechnology company focused on precision oncology. It uses structure-guided drug discovery and a computational chemistry platform to design alteration-specific therapies that target oncogenic drivers like AKT and KRAS. Based in San Diego, the company aims to accelerate development of first-in-class small molecules to provide targeted cancer treatments and inspire hope for patients affected by cancer.
No recent deals for this company.